← All Companies
QuidelOrtho Corp
QDEL · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
Business Summary PartI All references to the Company, we, our and us in this Annual Report refer to QuidelOrtho Corporation (QuidelOrtho) and its subsidiaries. References to fiscal year ended 2025, fiscal year ended 2024 and fiscal year ended 2023 in this Annual Report refer to the Companys fiscal years ended December28, 2025, December29, 2024 and December31, 2023, respectively. Refer to the Summary of Abbreviated Terms at the end of this Annual Report for definitions of terms used throughout this Annual Report....
Next Earnings Q2 FY2026 — expected 2026-08-18
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention QDEL discussed_in_filing Cybersecurity topic_mention QDEL discussed_in_filing Trusted Computing topic_mention QDEL discussed_in_filing Blockchain & Crypto topic_mention QDEL discussed_in_filing Supply Chain topic_mention QDEL discussed_in_filing Regulation topic_mention QDEL discussed_in_filing Cybersecurity topic_mention QDEL discussed_in_filing Trusted Computing topic_mention QDEL discussed_in_filing Blockchain & Crypto topic_mention QDEL discussed_in_filing Supply Chain topic_mention QDEL discussed_in_filing Regulation topic_mention QDEL discussed_in_filing Cybersecurity topic_mention QDEL discussed_in_filing Trusted Computing topic_mention QDEL discussed_in_filing Blockchain & Crypto topic_mention QDEL discussed_in_filing Supply Chain topic_mention QDEL discussed_in_filing Regulation topic_mention QDEL discussed_in_filing Cybersecurity topic_mention QDEL discussed_in_filing Trusted Computing topic_mention QDEL discussed_in_filing Blockchain & Crypto topic_mention QDEL discussed_in_filing Supply Chain topic_mention QDEL discussed_in_filing Regulation
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-02-19 2025-12-28 0001906324-26-000008 EDGAR 80K words 2025-02-27 2024-12-29 0001906324-25-000035 EDGAR — 2024-02-29 2023-12-31 0001906324-24-000011 EDGAR — 2023-02-23 2023-01-01 0001906324-23-000014 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-06 2025-09-28 0001906324-25-000160 EDGAR 23K words 2025-08-06 2025-06-29 0001906324-25-000151 EDGAR — 2025-05-08 2025-03-30 0001906324-25-000057 EDGAR — 2024-11-08 2024-09-29 0001906324-24-000049 EDGAR — 2024-08-01 2024-06-30 0001906324-24-000045 EDGAR — 2024-05-09 2024-03-31 0001906324-24-000032 EDGAR — 2023-11-02 2023-10-01 0001906324-23-000058 EDGAR — 2023-08-09 2023-07-02 0001906324-23-000046 EDGAR — 2023-05-04 2023-04-02 0001906324-23-000033 EDGAR — 2022-11-04 2022-10-02 0001906324-22-000033 EDGAR — 2022-08-05 2022-07-03 0001906324-22-000011 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-24 0001193125-26-120684 EDGAR 1K words 2026-02-13 0001193125-26-051461 EDGAR — 2026-02-11 0001906324-26-000003 EDGAR — 2026-02-05 0001193125-26-039440 EDGAR — 2025-11-10 0001193125-25-273317 EDGAR — 2025-11-05 0001906324-25-000158 EDGAR — 2025-08-21 0001193125-25-185355 EDGAR — 2025-08-05 0001906324-25-000150 EDGAR — 2025-05-27 0001193125-25-127604 EDGAR — 2025-05-07 0001906324-25-000055 EDGAR —
66 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001906324
Ticker QDEL
Exchange Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: b2d448a29d991f7f8ac583f0cfb9c758f3c71793c0d4fc02a88111153e038255
parent: 1451393c3d2465c0b8e9fbf9bd95d0bb4bca0644a92b57d8faa480a3ed6764b4
content hash: fbaf256703499798f6616838e7886d5216ae7207493a2cd610d78ea998b5fe75
signed: 2026-04-13T04:47:04.622Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf